SCHEMBL16168177

SCHEMBL16168177

N=C(N)c1c(-c2ccc(Oc3ccccc3)cc2)cnc(-c2ccc(C(N)=O)cc2)c1N

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PARP10 Q53GL7 6/20 0.51
▸ TNK2 Q07912 3/20 0.51
▸ BTK Q06187 2/20 0.44
▸ CHEK2 O96017 4/20 0.44
▸ MKNK1 Q9BUB5 1/20 0.44
▸ CAMKK2 Q96RR4 1/20 0.42
▸ PARP15 Q460N3 3/20 0.42
▸ PARP14 Q460N5 2/20 0.42
▸ ALDH1A1 P00352 1/20 0.42
▸ KMT2A Q03164 1/20 0.42
▸ PARP16 Q8N5Y8 1/20 0.42
▸ PARP11 Q9NR21 1/20 0.42
▸ PARP4 Q9UKK3 1/20 0.42
▸ SCN9A Q15858 1/20 0.42
▸ FEN1 P39748 1/20 0.41
▸ TNKS O95271 1/20 0.41
▸ TNKS2 Q9H2K2 1/20 0.41
▸ PARP2 Q9UGN5 1/20 0.41
▸ F2 P00734 1/20 0.40
▸ PRSS1 P07477 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18800757 0.93 TNK2 (0.49) PARP10TNK2BTKPARP15SCN9A
SCHEMBL18800753 0.92 BTK (0.49) TNK2BTKSCN9A
SCHEMBL18800492 0.91 BTK (0.48) TNK2BTKSCN9A
SCHEMBL18800616 0.90 BTK (0.47) TNK2BTKSCN9A
SCHEMBL18800564 0.89 BTK (0.47) TNK2BTKALDH1A1KMT2ASCN9A
SCHEMBL18800747 0.86 KMT2A (0.46) TNK2BTKALDH1A1KMT2A
SCHEMBL18800583 0.86 BTK (0.43) PARP10TNK2BTKALDH1A1SCN9A
SCHEMBL18800615 0.86 BTK (0.62) BTKKMT2A
SCHEMBL18800755 0.85 TNK2 (0.50) TNK2BTKCHEK2F2
SCHEMBL18800556 0.84 ATR (0.44) PARP10BTKPARP14ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2789615-B1 Azaindazoles as Btk kinase modulators and use thereof BRISTOL MYERS SQUIBB CO (US) 2017-05-03 — — EP disclosed
EP-2789615-A1 Azaindazoles as Btk kinase modulators and use thereof Bristol-Myers Squibb Company (US) 2014-10-15 — — EP disclosed
Send feedback